Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9621 |
High Similarity |
NPD2796 |
Approved |
0.9403 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9403 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9333 |
High Similarity |
NPD1549 |
Phase 2 |
0.8936 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8865 |
High Similarity |
NPD6799 |
Approved |
0.8836 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8836 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8832 |
High Similarity |
NPD1510 |
Phase 2 |
0.8828 |
High Similarity |
NPD7411 |
Suspended |
0.8815 |
High Similarity |
NPD1240 |
Approved |
0.8776 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8767 |
High Similarity |
NPD1934 |
Approved |
0.8707 |
High Similarity |
NPD7819 |
Suspended |
0.8692 |
High Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8686 |
High Similarity |
NPD1607 |
Approved |
0.8671 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8658 |
High Similarity |
NPD7075 |
Discontinued |
0.8639 |
High Similarity |
NPD6801 |
Discontinued |
0.863 |
High Similarity |
NPD4380 |
Phase 2 |
0.863 |
High Similarity |
NPD6599 |
Discontinued |
0.8543 |
High Similarity |
NPD5494 |
Approved |
0.8533 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8529 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8429 |
Intermediate Similarity |
NPD3748 |
Approved |
0.84 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8382 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8345 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8333 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8323 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8299 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8299 |
Intermediate Similarity |
NPD920 |
Approved |
0.8288 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8276 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8231 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8224 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8205 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8113 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8112 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8105 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8069 |
Intermediate Similarity |
NPD2654 |
Approved |
0.8052 |
Intermediate Similarity |
NPD3749 |
Approved |
0.805 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1933 |
Approved |
0.795 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7941 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7922 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7917 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7902 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7901 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7899 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7891 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7885 |
Intermediate Similarity |
NPD919 |
Approved |
0.7863 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7853 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7842 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7791 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD1247 |
Approved |
0.777 |
Intermediate Similarity |
NPD1203 |
Approved |
0.777 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7746 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD6099 |
Approved |
0.774 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7737 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7716 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7704 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7682 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7682 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7681 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2797 |
Approved |
0.764 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7639 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7639 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7613 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD2309 |
Approved |
0.76 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7593 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7591 |
Intermediate Similarity |
NPD17 |
Approved |
0.7586 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7566 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD943 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7482 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.747 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4662 |
Approved |
0.745 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7447 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7447 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7423 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7417 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7388 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7319 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7314 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD4622 |
Approved |
0.723 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7194 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7174 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7143 |
Intermediate Similarity |
NPD411 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5586 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5688 |
Approved |
0.7133 |
Intermediate Similarity |
NPD5689 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7114 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7114 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7105 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7075
|
Intermediate Similarity |
NPD3027 |
Phase 3 |